Researchers continue to excited about this new drug, a groundbreaking dual agonist showing significant outcomes in clinical trials for weight loss . It works by impacting both pathways : GLP-1 and GIP, https://saadlvgr403950.dbblog.net/14061447/this-new-prospect-for-size-loss